Faculty profile

Carl Laskin

Back to faculty

Associate ProfessorDepartment of MedicineUniversity of Toronto

Carl Laskin

Associate Professor

Department of Medicine

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
23 publications in the last five years, latest in 2026.
Senior (last) author on 2 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2017.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

157

Publications

9,646

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Antiphospholipid Antibodies Pregnancy Prospective Cohort Systemic Lupus Erythematosus

Latest papers

LBA:01:25 Increased risk of intrahepatic cholestasis of pregnancy in SLE women exposed to azathioprine
2026
Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial
Annals of the Rheumatic Diseases · 2025
Maternal autoantibodies to the sodium potassium pump α1 subunit AT1A1 and fetal autoimmune congenital heart block: a case-control study.
The Lancet. Rheumatology · 2025

All 157 publications

Latest funding

The Lupus prEGnAnCY (LEGACY) Cohort
CIHR · 2017 · Principal investigator
$100,000
The GRAVID Study: Generalized Reproductive Assistance and Vascular Illness Downstream
CIHR · 2011 · Co-investigator
$97,307
The STORK Study: Symptomatic Thrombosis and Occlusions following Reproductive Kindling
CIHR · 2011 · Co-investigator

All 3 grants and awards

From the 150 most recent of 157 publications.

LBA:01:25 Increased risk of intrahepatic cholestasis of pregnancy in SLE women exposed to azathioprine

Evelyne Vinet, Reem Farhat, Maria Zamora-M, Sang-Cheol Bae, Ann Elaine Clarke, M. Barber, Paul R Fortin, Zahi Touma, Carl A. Laskin, CHRISTINE A. PESCHKEN, Manuel F Ugarte-Gil, Alexandra C. Legge, Sasha B Bernatsky, Evelyne Vinet

2026Open Access

DOI: 10.1136/lupus-2026-el.422

Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial

David Ware Branch, Mimi Kim, Marta M. Guerra, Joseph Worden, Carl A. Laskin, Maria Teresa DeSancho, Inna V. Landres, Jason S. Knight, Haley S Slosberg, Margaret Minett, Jane E. Salmon

Annals of the Rheumatic Diseases202527 citationsOpen Access

DOI: 10.1016/j.ard.2025.02.012 PMID: 40483169

Maternal autoantibodies to the sodium potassium pump α1 subunit AT1A1 and fetal autoimmune congenital heart block: a case-control study.

Benjamin S, Vi L, Chatterjee D, Jaeggi ET, Ruffatti A, Hiraki LT, Sepiashvili L, Laskin CA, Fatah M, Tonello M, Dominguez D, Ng L, Lohbihler M, Luchessi AD, Hogarth K, Daoud A, Maynes JT, Protze S, Hamilton RM

The Lancet. Rheumatology20258 citations

DOI: 10.1016/s2665-9913(25)00092-x PMID: 40412415

A clinical care pathway for managing pregnancy in patients with inflammatory arthritis

Amiri N, Gamble M, Laskin C, Pavlova V, Troster S

Clinical Rheumatology20254 citationsOpen Access

DOI: 10.1007/s10067-025-07766-5

An educational tool to improve PREeclamPsia knowledge and Aspirin adheRence in lupus prEgnancies: the PREPARE trial.

Lee JE, Mendel A, Malhamé I, Barber MRW, Clarke AE, Fortin PR, Hanly JG, Legge A, Peschken C, Laskin CA, Touma Z, Urowitz MB, Bernatsky S, Vinet É

Rheumatology (Oxford, England)20254 citationsOpen Access

DOI: 10.1093/rheumatology/keaf334 PMID: 40578323

Genetics of Neonatal Lupus Erythematosus Risk and Specific Manifestations.

Misztal MC, Gold N, Cao J, Diaz T, Dominguez D, Thompson K, Jaeggi E, Knight AM, Laskin C, Ng L, Silverman ED, Hiraki LT

The Journal of rheumatology20253 citationsOpen Access

DOI: 10.3899/jrheum.2023-1036 PMID: 38825356

Long‐Term Outcomes of Children Born to Anti‐Ro Antibody–Positive Mothers With and Without Rheumatic Disease

Diaz T, Danguecan A, Dominguez D, Knight A, Laskin CA, Levy DM, Jaeggi E, Misztal M, Mandhane P, Moraes T

Arthritis Care and Research20252 citations

DOI: 10.1002/acr.25510

Pregnancy-associated exposure reduction to medications used for antiphospholipid syndrome: a systematic review.

Zarek J, Brydon A, Spitzer K, Laskin C, Ito S

EULAR rheumatology open20251 citationsOpen Access

DOI: 10.1016/j.ero.2025.03.001 PMID: 42367607

LONG-TERM OUTCOMES OF POSTNATAL IMMUNOSUPPRESSIVE THERAPY IN CHILDREN WITH CARDIAC NEONATAL LUPUS ERYTHEMATOSUS

Chinmayi Yathiraju, Kendal Thompson, Talia Diaz, Daniela Domínguez, Lindsay R. Freud, Robert Murray Hamilton, EDGAR T. JAEGGI, Andrea Knight, Carl A. Laskin, Earl D. Silverman, Linda T. Hiraki

The Journal of Rheumatology2025

DOI: 10.3899/jrheum.2025-0390.pv154

OP0273 CERTOLIZUMAB PEGOL TO PREVENT ADVERSE PREGNANCY OUTCOMES IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND LUPUS ANTICOAGULANT (IMPACT): RESULTS OF A PROSPECTIVE, SINGLE ARM, OPEN-LABEL, PHASE 2 TRIAL

David Ware Branch, Mimi Kim, Marta M. Guerra, Joseph Worden, Carl A. Laskin, Maria Teresa DeSancho, Inna V. Landres, J. Knight, Haley S Slosberg, Margaret Minett, Jane E Salmon

Annals of the Rheumatic Diseases2025Open Access

DOI: 10.1016/j.ard.2025.05.283

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Carl Laskin

Research

Latest papers

Latest funding

LBA:01:25 Increased risk of intrahepatic cholestasis of pregnancy in SLE women exposed to azathioprine

Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial

Maternal autoantibodies to the sodium potassium pump α1 subunit AT1A1 and fetal autoimmune congenital heart block: a case-control study.

A clinical care pathway for managing pregnancy in patients with inflammatory arthritis

An educational tool to improve PREeclamPsia knowledge and Aspirin adheRence in lupus prEgnancies: the PREPARE trial.

Genetics of Neonatal Lupus Erythematosus Risk and Specific Manifestations.

Long‐Term Outcomes of Children Born to Anti‐Ro Antibody–Positive Mothers With and Without Rheumatic Disease

Pregnancy-associated exposure reduction to medications used for antiphospholipid syndrome: a systematic review.

LONG-TERM OUTCOMES OF POSTNATAL IMMUNOSUPPRESSIVE THERAPY IN CHILDREN WITH CARDIAC NEONATAL LUPUS ERYTHEMATOSUS

OP0273 CERTOLIZUMAB PEGOL TO PREVENT ADVERSE PREGNANCY OUTCOMES IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND LUPUS ANTICOAGULANT (IMPACT): RESULTS OF A PROSPECTIVE, SINGLE ARM, OPEN-LABEL, PHASE 2 TRIAL

The Lupus prEGnAnCY (LEGACY) Cohort

The GRAVID Study: Generalized Reproductive Assistance and Vascular Illness Downstream

The STORK Study: Symptomatic Thrombosis and Occlusions following Reproductive Kindling

Frequent collaborators

Edgar Jaeggi

Natalie Dayan

Mark Crowther

John Kingdom

Linda Hiraki

Gideon Koren

Deshayne Fell

Julie Ray

Joel Ray

Olga Basso

Andrea Knight

Paul Fortin

Keith Jarvi

Bruce Mazer

Ann Clarke

Évelyne Vinet

Shinya Ito

Robert Casper

Marc Beltempo

Murray Urowitz

Greg Ryan

Rayfel Schneider

Carl Laskin

Research

Latest papers

Latest funding

LBA:01:25 Increased risk of intrahepatic cholestasis of pregnancy in SLE women exposed to azathioprine

Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial

Maternal autoantibodies to the sodium potassium pump &#x3b1;1 subunit AT1A1 and fetal autoimmune congenital heart block: a case-control study.

A clinical care pathway for managing pregnancy in patients with inflammatory arthritis

An educational tool to improve PREeclamPsia knowledge and Aspirin adheRence in lupus prEgnancies: the PREPARE trial.

Genetics of Neonatal Lupus Erythematosus Risk and Specific Manifestations.

Long‐Term Outcomes of Children Born to Anti‐Ro Antibody–Positive Mothers With and Without Rheumatic Disease

Pregnancy-associated exposure reduction to medications used for antiphospholipid syndrome: a systematic review.

LONG-TERM OUTCOMES OF POSTNATAL IMMUNOSUPPRESSIVE THERAPY IN CHILDREN WITH CARDIAC NEONATAL LUPUS ERYTHEMATOSUS

OP0273 CERTOLIZUMAB PEGOL TO PREVENT ADVERSE PREGNANCY OUTCOMES IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND LUPUS ANTICOAGULANT (IMPACT): RESULTS OF A PROSPECTIVE, SINGLE ARM, OPEN-LABEL, PHASE 2 TRIAL

The Lupus prEGnAnCY (LEGACY) Cohort

The GRAVID Study: Generalized Reproductive Assistance and Vascular Illness Downstream

The STORK Study: Symptomatic Thrombosis and Occlusions following Reproductive Kindling

Frequent collaborators

Edgar Jaeggi

Natalie Dayan

Mark Crowther

John Kingdom

Linda Hiraki

Gideon Koren

Deshayne Fell

Julie Ray

Joel Ray

Olga Basso

Andrea Knight

Paul Fortin

Keith Jarvi

Bruce Mazer

Ann Clarke

Évelyne Vinet

Shinya Ito

Robert Casper

Marc Beltempo

Murray Urowitz

Greg Ryan

Rayfel Schneider

Maternal autoantibodies to the sodium potassium pump α1 subunit AT1A1 and fetal autoimmune congenital heart block: a case-control study.